JP Morgan Maintains Overweight on Merit Medical Systems, Lowers Price Target to $77
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Robbie Marcus maintains Merit Medical Systems (NASDAQ:MMSI) with a Overweight and lowers the price target from $95 to $77.
JP Morgan analyst Robbie Marcus maintains Merit Medical Systems (NASDAQ:MMSI) with a Overweight and lowers the price target from $95 to $77.